FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people with type 2 diabetes lower their blood sugar and lose weight. The company is hopingContinue Reading
THURSDAY, April 17, 2025 (HealthDay News) — A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including respiratory syncytial virus (RSV), meningitis and a mosquito-borne illness called chikungunya. The panel, known as the Advisory Committee on Immunization Practices (ACIP), makes vaccine use recommendations toContinue Reading
THURSDAY, April 17, 2025 (HealthDay News) — Hepatitis A vaccinations could be lagging among men who have sex with men due to a mistrust of medicine, particularly among racial and ethnic minority groups, a new study says. Only about 60% of surveyed gay and bisexual men were fully vaccinated forContinue Reading
Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathyContinue Reading
The CheckMate-9DW trial showed significant overall survival benefit versus lenvatinib or sorafenibContinue Reading
TUESDAY, April 15, 2025 (HealthDay News) — People hospitalized for opioid use can better fight their addiction if their path to recovery begins in the hospital, a new study says. Opioid users who receive addiction consultation services during their hospital stay are significantly more likely to start taking addiction medsContinue Reading
New strategy aims to enhance drug safety, expedite evaluation process, and decrease animal experimentationContinue Reading
FRIDAY, April 11, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) now recommends extra measles protection for people traveling to areas with active outbreaks in the United States, CBS News reported. In an April 8 letter, the CDC advised health departments that travelers going toContinue Reading
WEDNESDAY, April 9, 2025 (HealthDay News) — An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondaryContinue Reading
FRIDAY, April 4, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1, but the agency now says it needs more information before moving forward. The Novavax shot is already available underContinue Reading